Jahnavi Phalkey named Director Of Science Gallery Bengaluru

2017-12-08 07:04:09

Jahnavi will head the establishment of Science Gallery Bengaluru with the Indian Institute of Science as lead partner, alongside the National Centre for Biological Sciences and Srishti Institute of Art, Design and Technology as collaborative partners.By Team ABLEScience Gallery International has announced the appointment of Dr Jahnavi Phalkey as the Founding Director of Science Gallery Bengaluru.J

Read more

Kewaunee Scientific Corporation bags CII Award

2017-12-08 06:57:58

Recognition was based on the assessment made by a team of qualified judges from CIIBy Team ABLENASDAQ-listed Kewaunee Scientific Corporation has reported that the Kewaunee International Team was honored by CII BE STAR RECOGNITIONS as the ‘Emerging Leader – Excellence in Customer Management, Services: Sector – Equipment’ in a function held at 25th National Quality Summit on November 25th, 2

Read more

Mylan launches HepBest in India

2017-12-08 06:57:00

Mylan launches HepBest for management of chronic Hepatitis B infection in IndiaBy Team ABLEMylan Pharmaceuticals Private Limited has launched HepBest 25 mg (tenofovir alafenamide, TAF), a once-daily tablet for the treatment of chronic hepatitis B in adults. According to World Health Organization (WHO) estimates, more than 2 billion people worldwide are infected with the hepatitis B virus (HBV), of

Read more

ICRISAT celebrates a decade of genomic advances in agriculture

2017-12-08 06:56:11

The Centre of Excellence in Genomics (CEG) at the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) is celebrating a decade of using modern genome analysis methods.By Team ABLEThe time taken to develop improved crop varieties has almost halved with the rapid strides made in genomics research and the last decade has seen the genomes of eight crops sequenced. This includes p

Read more

US FDA approves Mylan-Biocon’s biosimilar for cancer drug Herceptin

2017-12-08 06:54:39

Mylan and Biocon’s trastuzumab has been approved for launch in the US. To be sold under the name Ogivri, this is the first biosimilar  in the US for the treatment of breast cancer or stomach cancer.By Team ABLEThe US Food and Drug Administration (FDA) approved the biosimilar of Mylan NV and Biocon used in the treatment of breast and metastatic stomach cancer. Mylan-Biocon’s trastuzumab wi

Read more

Odisha Government signs MoU with four healthcare firms

2017-12-07 08:39:31

The Odisha government has signed four MoUs with different organizations for better delivery of healthcare service in the state.By Team ABLEThe MoUs were signed with Glocal Healthcare System Private Limited, Kolkata, Centre for Stem Cell Research, Christian Medical College, Vellore, Narayan Hrudayalaya and L V Prasad Eye Institute, Bhubaneswar.\"The MoUs with institutions of national repute for del

Read more

Health Ministry ties up with Rotary India to accomplish immunization target

2017-12-07 08:37:49

A Memorandum of Understanding (MoU) was signed between the Ministry of Health & Family Welfare (MoHFW) and Rotary India on Dec 7th. By Team ABLEA Memorandum of Understanding (MoU) was signed between the Ministry of Health & Family Welfare (MoHFW) and Rotary India on Dec 7th. The MoU signing ceremony was presided over by Shri J P Nadda, Union Minister of Health and Family Welfare. This MoU,

Read more

Health Minister J P Nadda reviews the progress of Intensified Mission Indradhanush

2017-12-07 08:21:47

To improve the coverage, Mission Indradhanush (MI) was launched with a strategy to focus on unvaccinated and partially vaccinated children in the pockets of low immunization coverageBy Team ABLEUnion Minister of Health and Family Welfare J P Nadda reviewed the progress of Intensified Mission Indradhanush (IMI) with the Health Ministers and Principal Secretaries of 24 states. In the review meeting,

Read more

India, Cuba sign MoU forging further collaborations in health sector

2017-12-07 08:16:52

One potential area is pharmaceutical and biotechnology. Cuba has made remarkable strides in the field of biotechnologyBy Team ABLEIndia and Cuba have signed a Memorandum of Understanding (MoU) for enhanced cooperation in the health sector, on December 6, 2017. Union Minister of Health & Family Welfare, J P Nadda and Dr Roberto Tomas Morales Ojeda, Public Health Minister of Cuba signed the MoU

Read more

Cipla launches Q-TIB globally, a single tablet for T.B. prophylaxis in HIV

2017-12-07 08:14:21

Cipla has received approval for its Q-TIB from WHO. According to Cipla, Q-TIB will help prevent tuberculosis infection in people living with HIVBy Team ABLEPharma major Cipla Ltd, on November 30th had announced that the company has received an approval for its product Q-TIB from World Health Organisation (WHO). Q-TIB is a novel fixed dose combination in a single tablet. This is the first time that

Read more